Publications by authors named "Disan Mulima"

Article Synopsis
  • Dolutegravir-based antiretroviral therapy (ART) is recommended for treating children and adolescents with HIV, but earlier studies raised concerns about its potential link to neural tube defects.
  • A sub-study was conducted within the ODYSSEY trial in Uganda to assess the impact of dolutegravir on folate and vitamin B12 levels, essential for neural tube development, compared to standard care treatments.
  • Results indicated that children on dolutegravir had significantly higher plasma and RBC folate levels at both week 4 and week ≥96 compared to those on standard treatment, suggesting a positive effect of dolutegravir on folate status.
View Article and Find Full Text PDF